If you are 100% confident your portfolio companies will hit their growth targets this year, then read no further. This is not for you.
If you are like many of our PE clients and have concerns about your portfolio company’s ability to make their number, then have them complete the Revenue Growth Diagnostic to realize these benefits:
- Determine the probability of your portfolio company making their 2018 revenue growth number.
- Highlight the strengths and weakness of their operating plans to ensure they will deliver on the expectations of the investment thesis.
- Understand how best in class CEOs in sponsor-owned companies are prioritizing 3-5 key growth vectors to drive alignment in their commercial spend.
Click on any one of the three options below to assess your portfolio company: